A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis
Status:
Withdrawn
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of three doses of orvepitant,
taken once a day, in the treatment of pruritus associated with atopic dermatitis.